Stefaan Van der Meulen

Managing Partner,
Syntactx Europe

Based outside Ghent, Belgium, Stefaan Van der Meulen heads the Syntactx offices in Europe as a Managing Partner and oversees business development in the Asia-Pacific region. Under his leadership, the Syntactx Europe and APAC teams work hand-in-hand with the Syntactx Corporate office while offering regional and country-specific expertise for local clinical and regulatory projects.

Stefaan began his career in the pharmaceutical industry working on early- and late-phase clinical research studies of various sizes and indications. While working at Novartis, he was a global co-driver for their risk-based monitoring initiative, a best practice that is now being applied at Syntactx. At Cordis, a medical device developer and manufacturer, Stefaan concentrated on first-in-human and pivotal studies before transitioning to Core Laboratory and product specialist activities. He also has experience in product life-cycle development from both a clinical and marketing perspective.

Stefaan holds a Master of Biomedical Sciences from Ghent University in Belgium. He is fluent in Dutch, English, and French, and proficient in Italian and German.

More People

Mark Adelman, MD

Chief Medical Officer

Richard Ouriel

Senior Vice President,
Clinical Sciences

Victoria Lee, MD

Associate Medical Director